dementia
Conditions
Interventions
Intervention: inhalation of essential oils containing linalool or cedrol components from bedtime to morning for 3 weeks.
control: inhalation of jojoba oil that does not contain sleep-inducing ingred
Sponsors
Komazawa Women's University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Those who meet all of the following A-F (partially modified diagnostic criteria for chronic insomnia disorder in the International Classification of Sleep Disorders 3rd Edition (American Society of Sleep Medicine, 2018)). A. The person complains of one or more of the following symptoms or the caregiver observes them. 1. Difficulty falling asleep 2. Difficulty in sustaining sleep 3. Early morning awakening 4. Refuse to go to bed at the appropriate time 5. I can't sleep without a caregiver B. The caregiver observes if one or more of the following symptoms associated with insomnia at night are complained by the person. 1. Fatigue or fatigue 2. Poor attention, concentration and memory 3. Dysfunction in social life, family life, and work life 4. I don't feel good, I'm irritated 5. Daytime sleepiness 6. Behavioral problems (eg overactivity, impulsivity, aggression) 7. Decreased motivation, energy and spontaneity 8. Prone to negligence and accidents 9. Worried about sleeping and dissatisfied C. Complain of the above-mentioned symptoms related to sleep / wakefulness, despite the appropriate sleep opportunities and environment. D. A and B occur at least 3 times a week. E. A and B are allowed for 3 months or longer. F. Sleep / wakefulness cannot be explained by other sleep disorders. Ii. Criteria for selecting dementia: The criteria for selecting elderly people with dementia are the degree of independence in daily life of elderly people with dementia II-IV prepared by the Ministry of Health, Labor and Welfare. Iii. Those who can voluntarily obtain consent to participate in the research from the person in writing or verbally.
Exclusion criteria
Exclusion criteria: 1. Those whose research start date falls within one month after entering the facility 2. Persons with sleep apnea syndrome 3. Hypnotics, anxiolytics, steroids, antihypertensive drugs, bronchodilators, histamine receptor blockers, interferon preparations, anti-Parkinson's disease from 2 weeks before the start date of the study period to the end date of the study period Those who have changed / added / decreased medicine. However, if insomnia symptoms have been observed even after taking these drugs for some time, they should be included in the study. 4. Those who do not have time to get out of bed all day long 5. Persons whose health condition is judged to be unstable by facility staff (research collaborators).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total sleep time,3 weeks average | — |
Secondary
| Measure | Time frame |
|---|---|
| 3 week average: Sleep efficiency Sleep onset latency Number of awakenings Midway awakening time Number of times you get out of bed Nap time BPSD score (NPI-NH) Long-term care burden score (NPI-NH) Total number of times in 3 weeks: Early morning awakening count | — |
Countries
Japan
Contacts
Public ContactAi Takeda
Komazawa Women's University Department of Nursing
Outcome results
None listed